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Abstract 
Background: Complementary remedies such as the Chinese herb ‘Sheng Ma’ (Black cohosh; Actaea racemosa ‘AR’) 
are being sought to overcome the shortcomings of conventional hormonal and surgical therapies developed for 
the treatment of polycystic ovary syndrome (PCOS). However, AR‑induced hepatotoxicity necessitates a cautionary 
warning to be labeled on its products as recommended by the United States Pharmacopeia, where four out of seven 
hepatotoxic cases in Sweden were possibly associated with black cohosh products.
Methods: We investigated the effects, safety, and molecular targets of black cohosh ethanolic extract and/or vitamin 
C on ovarian functionality and oxidative response in hyperandrogenism‑induced PCOS rats. A well‑established rat 
model using oral letrozole, daily, for 21 days was employed. The rats then received the AR extract with and without 
vitamin C for 28 days. The hormonal evaluation, antioxidant status, histopathological examination, immunohisto‑
chemical analysis, cell proliferation, and the expression ratio of the aromatase (Cyp19α1) gene were evaluated. Addi‑
tionally, holistic profiling of the AR arsenal of secondary metabolites was performed using ultra‑high‑performance liq‑
uid chromatography (UHPLC) coupled with quadrupole high‑resolution time of flight mass spectrometry (QTOF‑MS).
Results: Beneficial effects were exerted by AR in PCOS rats as antioxidant status, hormonal profile, lipid profile, glu‑
cose level, liver functions, and the induced Ki‑67 expression in the granulosa, theca cell layers and interstitial stromal 
cells were all improved. Notably, the combination of AR with vitamin C was not only more effective in reversing the 
dysregulated levels of testosterone, luteinizing hormone, and mRNA level of Cyp19α1 gene in the PCOS rat, but also 
safer. The combination regulated both ovarian and hepatic malondialdehyde (MDA) and glutathione (GSH) levels 
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Background
Polycystic ovary syndrome (PCOS) is a complex meta-
bolic–endocrine disorder [1] that affects 4–18% of 
women at the age of reproduction [2]. The genetic pre-
disposition to PCOS is uncertain, and no genetic screen-
ing test has been validated [3]. PCOS is characterized 
by anovulation, menstrual irregularity, amenorrhea, hir-
sutism and infertility [2]. Furthermore, various metabolic 
and clinical complications have been reported such as 
insulin resistance and diabetes, obesity, extensive coro-
nary artery disease, hypertension, endometrial hyperpla-
sia, ovarian and breast cancers [4, 5]. The secretion and 
metabolism of estrogens and androgens are disturbed 
in PCOS [6]. The leading cause of PCOS is the excessive 
androgen level [7], that induced by overstimulation of 
ovarian theca cells by gonadotropin-releasing hormone 
(GnRH) [8].
Various side effects are associated with chemical and 
hormonal PCOS therapies such as hyperplasia, uterine 
bleeding and uncertain risks [9, 10] along with consid-
erable cost [11]. Nonetheless, these therapies may not 
be effective in some cases. Therefore, several studies are 
focused on the investigation of complementary herbal 
medicine as a potential treatment of PCOS [9, 12–16]. 
For instance, promising effects of hops (Humulus lupu-
lus), female ginseng (Angelica sinensis), ginseng (Panax 
ginseng), liquorice (Glycyrrhiza glabra), black cohosh 
(Actaea racemosa) and kelp (Nereocystis luetkeana) were 
reported against PCOS [17].
Black cohosh (Actaea racemosa (AR) or formerly; 
Cimicifuga racemosa) is a common herbal treatment 
in Europe, Asia, Australia, and America for a variety of 
women’s health disorders [18–21]. Although the previous 
testing has been undertaken with regards to the effects of 
AR for various gynecological conditions as oligo/amenor-
rhea, hyperandrogenism and PCOS, the limited quantity 
of data and subsequent variability in quality warranted 
further research to be undertaken [22, 23]. Recent stud-
ies revealed the beneficial effect of black cohosh for treat-
ing postmenopausal symptoms, however, there is a shred 
of conflicting evidence concerning its hepatic safety 
[24–26]. The Medical Products Agency in Sweden found 
that four of seven hepatotoxic cases were possibly associ-
ated with black cohosh products, but three of those were 
confused by the use of other liver injury-related drugs 
[27]. The consumption of black cohosh was correlated 
with acute liver injury [28]. Additionally, the analysis of 
the case reports from the Expert Committee of the US 
Pharmacopeia’s Council of Experts and others led to 
the recommendation of cautionary warning in regard to 
hepatotoxicity should be labeled for AR products [29, 30]. 
However, the Council made its analysis using the Naranjo 
scale, which has already then been considered not to be 
of use in the assessment of liver case reports. Still, none 
of the 30 examined cases were found to be indicative of 
a probable causality by AR, a finding that has later been 
confirmed using the Roussel Uclaf Causality Assessment 
Method (RUCAM) scale [30].
Protective action of vitamin C/ascorbic acid against 
hepatotoxicity has been reported [31, 32]. Moreover, 
antioxidants such as vitamin C have been associated with 
fertility enhancement depending on their role as a reduc-
ing agent [33–36]. Ascorbic acid has three reproductive 
actions, where it is needed for collagen biosynthesis, ster-
oid and peptide hormone production and for the protec-
tion of cells from free radicals [34]. Ascorbic acid also 
showed a chemo-protective effect against degenerative 
changes in ovarian tissue [37].
The objectives of the present study were to determine 
the mechanism and molecular targets of AR for the treat-
ment of PCOS along with any anticipated combination 
benefits with vitamin C and to investigate hepatic safety. 
In addition to the holistic metabolomics profiling via 
Ultra performance liquid chromatography (UPLC) cou-
pled with high-definition mass spectrometry (HMDS) 
of AR where ion mobility spectroscopy (IMS) will be 
utilized for a higher confidence level of identification to 
support future chemometric and/or bioactive molecular 
network studies identifying potential active metabolites.
Materials and methods
Preparation of AR extract
Black cohosh roots and rhizomes were obtained from 
medicinal plant store (Haraz) in Cairo, Egypt and were 
authenticated at the herbarium of Botany Depart-
ment, Faculty of Science, Cairo University, Giza, Egypt, 
using American Herbal Pharmacopoeia [38]. Plant sam-
ple (0.5 kg) was initially washed with running tap water 
with histological improvement observed in the liver and ovaries. In addition, the untargeted metabolomic profiling 
enabled the identification of 61 metabolites allocated in five major chemical classes.
Conclusion: This study demonstrated the benefit of the combinatorial effects of AR and vitamin C in mitigating the 
reproductive and metabolic disorders associated with PCOS with the elimination of AR hepatotoxic risk.
Keywords: Actaea racemosa, Vitamin C, Polycystic ovarian syndrome, Hepatotoxicity, PCOS rat model, UPLC‑
QTOF‑MS, Metabolomic profiling
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followed by deionized distilled water, sun-dried and 
grounded, then was extracted by 70% ethanol (2 × 1.5 L) 
at 25  °C for 48  h. Solvents were evaporated under vac-
uum, in an evaporator (Büchi, Switzerland), at 45–55 °C 
and 60 rpm [39]. The obtained viscous extract was dried 
at 37  °C for 24  h, then weighed and percentage yields 
were calculated (7.6% w/w). The extract was stored at 
− 20  °C until use, where it was freshly dissolved in 0.5% 
carboxy methylcellulose (CMC) for the preparation of 
doses.
UPLC–MS fingerprinting of the AR extract
The AR extract was dissolved in acetonitrile (2  mg/mL) 
and centrifuged at 13,000g for 15 min at 4 °C. The super-
natant was filtered through a 0.2  μm PTFE filter while 
the first 2 mL were discarded. The metabolomic analysis 
was performed in ACQUITY UPLC (Waters, USA) cou-
pled with SYNAPT G2-S high-definition mass spectrom-
etry (Waters Corp, Manchester, England) as reported in 
the literature [40]. Briefly, a 5 µL sample was injected at 
a flow rate of 400  µL/min. Chromatographic separation 
was achieved using ACQUITY UPLC HSS T3 Column 
(1.8  μm, 2.1 × 150  mm, Waters Corporation, Milford, 
USA). The column temperature was kept at 45  °C and 
gradient elution was implemented utilizing water with 
0.1% formic acid (A), and acetonitrile with 0.1% formic 
acid (B). Initially, 1% of the mobile phase B was used for 
2  min, and linearly inclined as the following gradient: 
35–60% B (2–4  min), 60–80% B (4–8  min), and 99% B 
(8–8.5 min) and finally declined to 10% B till 11.5 min.
G2-S high-definition mass spectrometer (HDMS) 
(Waters Corp, Manchester, England) equipped with 
Z-spray source controlled by MassLynx v4.1 was used for 
mass spectrometry analysis in both positive and negative 
ESI ionization modes using HDMS mode of operation. 
The scanning mode parameters were: source tempera-
ture; 120  °C, desolvation temperature; 500  °C, cone gas 
flow; 50  L/h, desolvation gas flow; 1000  L/h, collision 
energy ramp; 20–50  eV, capillary voltage; 2.5  kV, and 
acquisition mass range; 50–1200 m/z [41]. Data acquired 
in a profile mode and corrected with separate lock mass 
spray switching between the injected samples and exter-
nal reference permitting the MassLynx to continuously 
ensure mass analysis accuracy. Leucine enkephaline 
(1  ng/μL) was used as an external reference in 1:1 ace-
tonitrile–water containing 0.1% formic acid at a flow rate 
5  uL/min via a lock-Spray interface, generating a refer-
ence ion for positive ion mode [M−H]+ and negative ion 
mode [M−H]− of 556.2771 and 554.261 m/z, respectively 
[42].
Three technical replicates were implemented in a ran-
domized batch sequence. To enable proper column equi-
libration and conditioning, the mobile phase was run for 
1.5 h, followed by six quality control (QC) samples before 
each batch analysis. In line with the published guide-
lines and to overcome the UPLC–MS analytical drifts, 
QC samples were injected at regular intervals during the 
experimental sequence [43]. Features were considered 
reproducible if their coefficient of variation (CV) among 
the sample replicates were < 25%, and the fold change 
(FC) > 2, ANOVA P-value and Q value < 0.01 against 
blank samples Q value is an adjusted P-value, calculated 
using an optimized false discovery rate (FDR) approach.
Progenesis QI software (Waters Corp., USA) was 
used for data processing and putative identification of 
metabolites of interest by comparison with literature and 
available databases such as metabolomic profiling CCS 
library (Waters Corp., USA), LipidBlast and Progen-
esis MetaScope imported databases including HMDB, 
MONA, and GNPS and Chemspider imported data 
sources such as NIST and PlantCys.
In vivo experiments
The experimental protocol was approved by the Institu-
tional Animal Care and Use Committee of Cairo Univer-
sity (CU-IACUC; VetCU11112018017).
Virgin, cyclic, adult female Wistar Albino rats (160–
200  g) were used in this study. Animals were acquired 
from Laboratory Animal Colony, Helwan, Egypt, and 
housed in the animal house of the Faculty of Veterinary 
Medicine, Cairo University, Egypt, and allowed to accli-
matize for 2  weeks. During the study, all animals were 
caged in standard polypropylene cages and maintained 
in a controlled environment of (22 ± 3)  °C temperature, 
(55 ± 5) % humidity and a 12 h light/dark cycle. The rats 
were provided with a standard diet and water ad libitum.
Experimental protocol
Forty-eight female rats were randomly allocated into six 
groups of eight each. Animals of group one served as nega-
tive control and received a daily oral dose of (1 mL) of the 
vehicle (0.5% CMC) using gavage for 49 days. The induc-
tion of PCOS was done guided by an established rat model 
that was previously described [44]. Animals of groups two 
to six received letrozole (LTZ) (Natco Pharma Limited 
Hyderabad) at a dose of 1 mg/kg dissolved in 0.5% CMC 
once daily for 21  days for induction of PCOS. Different 
samples (vehicle, standard and extracts) were then received 
orally for 28 days. Group 2 (positive control) received only 
the vehicle and Group 3 received clomiphene citrate in 
0.5% of CMC at a dosage of 1 mg/kg (Fertyl-Super® tablets 
were obtained from Ar-Ex Laboratories Private Limited, 
Goregaon (E), Mumbai) as a standard ovulation induction 
drug [45]. Groups (4–6) were treated for 28 days with AR 
extract; 7.14 mg/kg, vitamin C; 500 mg/kg and AR extract 
with vitamin C, respectively. From day 6 of treatment, daily 
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vaginal smears of all rats were obtained for ovulation moni-
toring, where PCOS was suggested by an indiscriminate 
estrous cycle with a prolonged diestrus phase [46, 47]. On 
day 50 of the study, all the rats were anesthetized with keta-
mine 91 mg/kg, i.p. Duplicate blood samples were collected 
in sodium heparin tubes for separation of plasma and in 
gel separator tubes for collection of serum samples. The 
serum was separated by blood centrifugation at 3000g at 
4 °C for 10 min and used for different biochemical assays. 
The animals were then sacrificed, ovaries and uteruses 
excised, cleaned of fat, weighed and divided into triplicates; 
two sets; stored at − 80 °C to be used for real-time reverse 
transcriptase-PCR and antioxidant assays. Another set of 
ovaries in addition to liver tissue were fixed in 10% neutral 
buffered formalin for histopathological examination. The 
relative weight of the ovaries was calculated as the ratio 
of the ovary (wet weight in mg) to the body weight (g) for 
each animal on the day of scarification.
Hormonal profile
Serum total testosterone was measured using a commercial 
ELISA kit (Chemux bioscience Inc, USA) and the beta sub-
unit chain of luteinizing hormone (LH) level was measured 
using rat lutropin subunit beta ELISA kit (EIAab, China) 
following the instructions of the manufacturers.
Malondialdehyde (MDA) and antioxidants biomarkers 
determinations
Ovarian and liver tissues were separately homogenized in 
10 mL cold buffer per gram tissue using a glass homoge-
nizer then tissue homogenate was centrifuged at 5000 rpm 
for 15 min at + 4 °C. This buffer consists of 50 mM potas-
sium phosphate with a pH 7.5 for MDA and 50  mM 
potassium phosphate with a pH 7.5 and 1  mM ethylen-
ediaminetetraacetic acid (EDTA) for reduced glutathione 
(GSH). The supernatant was used to measure GSH and 
MDA concentrations according to the standard protocols 
[48, 49].
Biochemical parameters
Serum glucose level, lipid profile [cholesterol, triglyc-
erides, and high-density lipoproteins (HDL)] and liver 
enzymes [alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST)] were measured using commercial 
kits (Spectrum, Egypt). The very low-density lipoprotein 
(VLDL) and low-density lipoprotein (LDL) concentration 
was calculated as follows:
(VLDL) = triglycerides/5
(LDL) = total cholesterol−(HDL+ VLDL)
Histopathological examination
Ovaries and liver from different groups were collected 
and fixed in 10% neutral-buffered formalin and pro-
cessed to obtain 3–4  µm paraffin-embedded sections. 
The sections were stained with hematoxylin and eosin 
(H&E) and the morphometric analysis of the ovaries 
was performed [50, 51]. The number of follicular cysts, 
its average and diameter alongside the thickness of 
granulosa cell layer and the thickness of theca cell lay-
ers were measured.
Immunohistochemical analysis
The tissue sections were deparaffinized, rehydrated 
and pre-treated with 10  mM citrate buffer for anti-
genic retrieval. Sections were incubated overnight at 
4  °C in a humidified chamber with the following pri-
mary antibody: rabbit monoclonal anti-Ki 67 antibody 
(Dako, Denmark) in 1:25 dilution. The tissue sections 
were incubated with a biotinylated goat anti-rabbit and 
mouse antibody (Thermo Scientific, USA), streptavidin 
peroxidase (Thermo scientific, USA) and 3,3′-diam-
inobenzidine tetrahydrochloride (DAB, Sigma). The 
slides were counterstained with Mayer’s hematoxylin 
then dehydrated and mounted. The primary antibody 
was replaced by PBS for negative controls. The stained 
sections were analyzed by Leica Qwin 500 Image Ana-
lyzer (Leica, Cambridge, England). In each field, the 
immunolabeled dark brown areas were recorded. The 
percentage of positively stained area in the granulosa 
cell layer, theca cell layers and interstitial stromal cell 
layer was calculated [52].
Quantitative real‑time PCR for aromatase (Cyp19α1) gene
Total RNA was extracted from female rat ovarian tis-
sue samples using RNeasy mini kit (Qiagen, Hilden, 
Germany). The quantity and purity of the total RNA 
were measured by the NanoDrop spectrophotometer. 
The cDNA synthesis was carried out using reverse tran-
scriptase (Invitrogen, California, USA) and oligo-dT 
following the manufacturer protocol. The cDNA sam-
ples were then submitted to qPCR using the following 
forward (5′-CTG CTG ATC ATG GGC CTC CT-3′) and 
reverse (5′-CTC CAC AGG CTC GGG TTG TT-3′) primer 
pairs for Cyp19α1 gene. The cDNA was amplified by 40 
cycles of denaturation at 95  °C for 45  s, annealing at 
59 °C for 45 s and extension at 72 °C for 45 s. The 95 °C 
step was extended to 4 min during the first cycle. The 
amplicon size was confirmed by 2% agarose gel electro-
phoresis stained with SYBR Safe DNA gel stain (Invit-
rogen). The β-actin gene was furtherly amplified in the 
same reaction to serve as the reference gene [53]. Each 
measurement was repeated three times, and the values 
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were used to calculate the gene/β-actin ratio, with a 
value of 1.0 used as the control (calibrator) and the nor-
malized expression ratio was calculated [54].
Statistical analysis
The different analytical measurements in the biologi-
cal samples were carried out in triplicate and results are 
expressed as the mean ± SD, a, b, c, d superscripts indicate 
statistical significance compared to the negative con-
trol group at P < 0.05 (n = 5). Data for multiple variable 
comparisons were analyzed by one-way analysis of vari-
ance (ANOVA) test to analyze the significant differences 




Metabolites were tentatively identified based on their 
accurate mass, isotopic distribution, fragmentation pat-
terns, comparison with common mass libraries alongside 
the dictionary of natural products (CRC Press, Taylor & 
Francis Group) and the reported literature. The untar-
geted metabolomic analysis enabled the putative iden-
tification of 61 compounds in both ionization modes 
and their structures were allocated as 13 flavonoids and 
glycosides, 12 fatty acids/lipids, 10 tannins, seven triter-
penes, six steroids, two miscellaneous terpenoids, two 
carbohydrates and one phenolic acid derivative (Addi-
tional file 1: Table S1, Figure S1–S43).
Relative ovarian and uterine weights
In general, the relative weights of both organs were 
reduced in all groups after treatment compared to the 
PCOS group. Nevertheless, these differences were signifi-
cant for ovaries and insignificant for the uterus (Fig. 1).
Hormonal profiles
Induction of PCOS significantly increased LH and tes-
tosterone concentrations compared to the negative con-
trol group. However, rats treated with AR extract and 
its combination with vitamin C for 28 days showed sig-
nificantly lowered LH and testosterone levels. The com-
bination group provoked a superior hormonal effect, in 
contrast to vitamin C which displayed the least effect 
(Fig. 2a, b).
Oxidative stress biomarkers in ovary and liver tissues
Induction of PCOS significantly increased MDA levels, 
while GSH activity was significantly decreased compared 
to the negative control. Actaea racemosa hydroethanolic 
extract with and without vitamin C restored normal 
ovarian MDA and GSH activities (Fig. 3a, b). Figure 4a, 
b demonstrated the hepatic MDA and GSH activities, 
where the exerted mild hepatic oxidative stress by AR 
and to less extent by LTZ in the PCOS model group, was 
prevented in the combination group (AR with vitamin C).
Biochemical parameters
The changes in lipid profile (total cholesterol, triglycer-
ide, LDL cholesterol, VLDL cholesterol), glucose concen-
trations, and the activities of ALT and AST were reported 
in Table 1. Interestingly, ALT and AST activities were sig-
nificantly increased in both AR and PCOS groups when 
compared with the negative control group. Nonetheless, 
they were significantly decreased in the vitamin C group 
and to a lesser extent in the combination group.
Histopathology of ovaries
The negative control group showed normal ovary histol-
ogy in the form of multiple follicles at different stages of 
development with normal granulosa, theca and intersti-
tial stromal cell layers in addition to presence of various 
corpora lutea (Fig. 5a, b). PCOS group revealed numer-
ous ovarian cysts in addition to small follicles in the early 
developmental stage and without any evidence of the 
existence of corpora lutea (Fig.  5c). The follicular walls 
of the cystic follicle contained a very thin layer of flat-
tening granulosa cells (Fig. 5d) that most of them exhib-
ited necrosis and apoptosis. The theca cell layers showed 
marked proliferation of theca interna and theca externa 
cells. Some ovarian cysts did not contain any granulosa 
cells with only theca interna and theca externa cells. The 
granulosa cell layers of other ovarian cysts were hyper-
plastic and folded. The interstitial stromal cell layer 
was very thick with proliferated and hyperplastic cells 
Fig. 1 Effect of Actaea racemosa (AR) extract and/or vitamin 
C on relative ovarian and uterine weights in letrozole induced 
polycystic ovary syndrome (PCOS) rat model. Values are presented as 
Mean ± SD, where means carrying different letters are significantly 
different at P < 0.05 (n = 5)
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Fig. 2 Effect of Actaea racemosa (AR) extract and/or vitamin C on a Beta subunit LH level b testosterone level in letrozole induced polycystic ovary 







































































Fig. 3 Effect of Actaea racemosa (AR) extract and/or vitamin C on ovarian a MDA level b GSH activity in letrozole induced polycystic ovary 
































































Fig. 4 Effect of Actaea racemosa (AR) extract and/or vitamin C on hepatic a MDA level b GSH activity in letrozole induced polycystic ovary 
syndrome (PCOS) rat model. Values are presented as Mean ± SD, where means carrying different letters are significantly different at P < 0.05 (n = 5)
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forming a cord-like structure. The same ovarian archi-
tecture was observed in the vitamin C treated group 
(Fig. 6c, d). The groups treated with clomiphene (Fig. 5e, 
f ), AR extract (Fig. 6a, b) and AR combined with vitamin 
C (Fig. 6e, f ) restored the ovarian functions and showed 
a reduction in the number of ovarian cysts, restora-
tion of granulosa cell thickness and presence of corpora 
lutea. Furtherly, the morphometric analysis of ovaries in 
the different experimental groups revealed a significant 
reduction in the number and diameter of ovarian cysts 
with a significant restoration of the granulosa cell layer 
thickness and a significant reduction in both theca cells 
compared to PCOS treated groups (Fig. 7a–d).
Immunohistochemical analysis of Ki‑76 expression 
in ovaries
Figure  8 summarizes the results of immunohistochemi-
cal analysis of Ki-67, a cell proliferation marker and its 
expression in the granulosa cell, theca cell and intersti-
tial stromal cells of the ovaries among different groups. 
Ovaries in the negative control group showed strong 
immunopositivity to Ki-67 expression in the granulosa 
cell layer of the follicles (Fig. 8a). Both PCOS and vitamin 
C treated groups revealed weak immunoreactivity in the 
granulosa cell layer and strong immunopositivity in the 
theca cell and interstitial stromal cell layers (Fig.  8b, e). 
The groups treated with clomiphene, AR and AR com-
bined with vitamin C showed strong immunopositivity in 
the granulosa cell layer of follicles with weak immunore-
activity in the theca cell and interstitial stromal cell layers 
(Fig.  8c, d and f ). The morphometric analysis of differ-
ent regions of the ovary was performed in the different 
treated groups. Notably, a significant increase in the per-
centage of Ki-67 expression in the granulosa cell layer 
(Fig.  9a) was demonstrated in the groups treated with 
clomiphene, AR and AR with vitamin C compared to the 
PCOS group unlike its significantly decreased expression 
in both theca cells and interstitial cells (Fig. 9b, c).
Histopathological examination of liver
The livers of the negative control and vitamin C treated 
groups revealed a normal hepatic architecture (Fig. 10a, 
e). The livers of PCOS and clomiphene treated groups 
showed moderate and mild vacuolar degeneration with 
single hepatocyte necrosis, respectively (Fig.  10b, c). 
The liver of AR treated groups revealed moderate vacu-
olar degeneration, apoptosis, hepatocellular necrosis 
(Fig.  10d) and sinusoidal dilation with leukocytosis. 
However, the group treated with AR combined with vita-
min C exhibited marked improvement of the previously 
described hepatic lesions induced by AR extract treat-
ment alone. Additionally, mild vacuolar degeneration and 
sporadic cell necrosis were demonstrated in the combi-
nation-treated group (Fig. 10f ).
Quantitative real‑time PCR for aromatase Cyp19α1
Real-time PCR was implemented to evaluate the mRNA 
expression level of the aromatase enzyme which is a key 
enzyme in the steroid biosynthesis pathway. The quan-
titative real-time PCR analysis for the Cyp19α1 gene 
in ovarian tissue from different groups showed that its 
mRNA expression level was significantly downregulated 
in the PCOS group compared to the negative control. 
However, the groups treated with AR extract and/or vita-
min C significantly upregulated the mRNA expression 
level for Cyp19α1 where the combination treatment was 
more effective (Fig. 11).
Discussion
Regardless the growing literature on the AR effectiveness 
for menopausal symptoms, definite assumptions on its 
exact mechanism of action cannot be deduced from clini-
cal studies not only related to blinding issues, but also 
to the fact that such things require a very special study 
design [55]. In the present study, the plethora of active 
secondary metabolites such as triterpenes, steroids, fla-
vonoids, and tannins of the black cohosh root ethanolic 
Table 1 Effect of Actaea racemosa (AR) extract and/or vitamin C on lipid profile, glucose level, liver function tests in letrozole induced 
polycystic ovary syndrome (PCOS) rat model
Values are presented as Mean ± SD, where means carrying different superscript letters are significantly different at P < 0.05 (n = 5)
Parameters Normal PCOS Clomiphene AR Vitamin C AR and Vitamin C
Cholesterol (mg/dL) 104.8 ± 4.5a 148.78 ± 1.6c 141.5 ± 3.2c 143.3 ± 5.94c 115.9 ± 2.64b 121.8 ± 4.73b
Triglyceride (mg/dL) 44.03 ± 4.1a 72.24 ± 3.81d 74.51 ± 4.1d 70.99 ± 3.69d 53.52 ± 0.86b 67.23 ± 3.11c
HDL (mg/dL) 76.57 ± 3.1a 58.42 ± 1.1c 57.66 ± 1.8c 55.11 ± 5.08c 66.23 ± 1.38b 63.44 ± 3.02b
LDL (mg/dL) 19.46 ± 2.2a 75.92 ± 0.4c 73.54 ± 1.12c 72.14 ± 1.49c 29.17 ± 1.03b 31.69 ± 2.13b
VLDL (mg/dL) 8.80 ± 0.8a 14.44 ± 0.8c 15.30 ± 0.92c 15.79 ± 0.74c 10.5 ± 0.17b 11.65 ± 0.62b
Glucose (mg/dL) 82.06 ± 4.3a 128.4 ± 0.8c 123.03 ± 1.39c 130.13 ± 2.5c 104.4 ± 2.9b 107.34 ± 1.2b
ALT(U/L) 19.27 ± 1.1a 36.32 ± 3.76c 31.44 ± 2.1b 94.85 ± 6.20d 22.35 ± 1.77a 24.22 ± 1.89ab
AST (U/L) 34.16 ± 1.3a 51.43 ± 4.85c 44.46 ± 2.47b 93.96 ± 7.14d 36.41 ± 3.17a 40.82 ± 2.2ab
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extract have been tentatively identified using UPLC-
HDMS (Additional file 1: Table S1). An extra dimension 
of separation was achieved via IMS based on the size, 
shape and charge of the analytes, where the characteristic 
CCS values were reported and could be used in combina-
tion with other molecular identifiers to enhance the con-
fidence level of metabolite recognition.
The efficacy of LTZ rat model in the induction of PCOS 
is well established and represents the human PCOS in 
various aspects [16, 56, 57] where the oxidative stress 
may be associated with the pathogenesis of PCOS [58]. 
The oxidative stress induced by LTZ in ovaries [59] was 
similar to that observed in natural PCOS [6]. Our results 
showed a significant increase in MDA level and reduc-
tion in GSH activity in the PCOS model, which may be 
attributable to the increased oxidation of biomolecules 
resulting in excessive peroxidation and consequent tis-
sue deterioration by ROS-mediated mechanisms [60]. 
The provoked enhancement in ovarian MDA and GSH 
activities by AR may be associated with its enzymatic 
Fig. 5 Photomicrographs of hematoxylin and eosin stained sections of ovaries in different experimental groups. Rectangle refers to an area with 
higher magnification in the next picture. a Ovary of negative control group showing the normal histological picture. b Normal secondary follicle. 
c Ovary of PCOS group showing multiple ovarian cysts. d Ovarian cyst with a thin layer of flattens granulosa cells. e, f Clomiphene treated group 
showing a reduction in the number of ovarian cysts and restoration of granulosa cell thickness
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antioxidant mechanisms for PCOS treatment. Further-
more, the effect of AR and vitamin C combination on the 
regulation of ovarian MDA and GSH was statistically sig-
nificant compared to the single treatments (Fig. 3).
In LTZ model of PCOS, the conversion of androgen 
substrates into estrogens in the granulosa cells was 
blocked leading to an accumulation of androgen [56]. 
As a result, early luteinization of the ovarian granular 
cell layer and a cessation of follicular development with 
eventual anovulation or poor ovulation will be antici-
pated [61]. Moreover, theca cell layers are responsible 
for the synthesis of androgen [62]. In our study, LTZ 
treated group exhibited numerous ovarian cysts with-
out any evidence of corpora lutea where the follicular 
walls contained a very thin layer of flattening granulosa 
cells with a marked proliferation of both theca interna 
and theca externa cells contributing to hyperandro-
genism (Fig.  6), similar findings have previously been 
Fig. 6 Photomicrographs of hematoxylin and eosin stained sections of ovaries in different experimental groups. Rectangle refers to an area with 
higher magnification in the next picture. a Ovary of Actaea racemosa (AR) group showing a marked reduction in the number of ovarian cysts with 
the presence of growing follicles. b Presence of corpora lutea. c Ovary of vitamin C treated group showing polycystic ovary. d Ovarian cyst with 
degenerated and necrosed granulosa cell layer. e Actaea racemosa (AR) combined with vitamin C treated group showing a marked reduction in the 
number of cysts with the presence of secondary follicles and corpora lutea. f Follicle showing proliferated granulosa cell layer
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published [44, 51]. Interestingly, both the AR and the 
combination-treated groups restored the ovarian func-
tions of LTZ induced-PCOS model shown by the resto-
ration of granulosa cell thickness, the reduction of both 
thecal cell layers and the presence of corpora lutea.
Previous studies have shown that ovarian cysts were 
formed by apoptosis of both ovarian oocytes and gran-
ulosa cells, where Ki-67 can be used as an indicator for 
cellular proliferation [63]. In our work, we observed 
a higher expression of Ki-67 in the theca cell layers 
responsible for excess androgen production and in the 
interstitial cells in the PCOS group [44]. The groups 
treated with AR with and without vitamin C showed 
significant intense immunolabeling of Ki-67 in the 
granulosa cell layer with weak immunolabeling of Ki-67 
in the theca cell layers and interstitial cells, suggesting 
their role in the reduction of the high androgen level 
induced by PCOS. This finding outlined that AR could 
be a useful therapeutic approach in the case of PCOS 
by protecting the granulosa cell layer from apoptosis 
and necrosis and it could help in their maintenance and 
proliferation with androgen level reduction.
The androgen aromatization to estradiol in domi-
nant follicles is conducted in the granulosa cells by the 
aromatase enzyme. Aromatase (Cyp19α1) is a key ster-
oidogenic enzyme that separately catalyzes the conver-
sion of testosterone to estradiol and estrone. Aromatase 
is encoded by the Cyp19α1 gene [64]. Intriguingly, the 
Cyp19α1 encoding gene can be included as a major risk 
determinant for PCOS [65]. Our findings unveiled a sig-
nificant downregulation of Cyp19α1 mRNA expression 
level in PCOS ovary tissues. These results were consistent 
with previously published data [16, 65, 66]. Remarkably, 
the AR and vitamin C combination showed superior and 
significant gene upregulation versus single treatments. 
Cyp19α1 expression could be regularly suppressed in 
PCOS ovaries owing to the promoter hypermethyla-
tion such as the promoter hypermethylation of Cyp19α1 
which may play a key role in the PCOS pathogenesis 
[67]. Also, testosterone was reported as a crucial factor 
Fig. 7 Morphometrical analysis of ovaries in the different treated groups. a Number of ovarian cysts per ovary. b Mean diameter of follicular cysts. 
c Granulosa cell thickness. d Theca cells thickness. Values with different superscripts are significantly different (P < 0.05). PCOS; polycystic ovary 
syndrome, AR; Actaea racemose, Vit. C; vitamin C
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responsible for aromatase downregulation in PCOS with 
the downregulation of both aromatase mRNA and pro-
tein levels in cultured luteinized granulosa cells [66]. The 
present study proposed the reversal of PCOS downreg-
ulation of the steroidogenic Cyp19α1 gene expression 
as a possible contributing mechanism for the beneficial 
effects of AR on PCOS with superior effect when com-
bined with vitamin C.
The reported elevation in testosterone and LH hor-
mones in LTZ induced PCOS rat models [9, 68, 69] 
were significantly restored by AR (Fig.  2a, b). Similar 
data were reported on the ovariectomized rats [70] and 
isolated cells from ovariectomized rats [22, 71]. That 
was probably mediated by interference with the LTZ 
inhibitory effect on androgen aromatization, prevent-
ing the excessive androgens accumulation in the ovaries 
Fig. 8 Photomicrographs of regions of ovaries showing immunohistochemical expression of Ki‑67 in the different treated groups (×200). a 
Negative control group showing strong immunopositive staining in the granulosa cell layer with weak immunoreactivity in the theca cells and 
stromal cells. b PCOS group showing strong immunopositive reaction in theca cells and interstitial stromal cells. c Clomiphene treated group 
showing strong immunopositive staining in the granulosa cell layer. d Actaea racemosa (AR) treated group showing strong immunolabeling in 
granulosa cell layer and slight immunopositive staining in theca cells and stromal cells. e Vitamin C group showing intense immunolabeling in the 
theca cells and interstitial stromal cells. f AR combined with vitamin C group showing very strong immunopositive staining in granulosa cell layer 
with a faint reaction in the theca cells and interstitial stromal cells
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as mentioned before. Moreover, AR has an estrogen-
like effect, where it acts directly on the hypothalamus 
to decrease GnRH and the subsequent reduction of LH 
hormone [72, 73].
The hormonal disorders in PCOS are combined with 
metabolic disorders. High testosterone concentrations in 
PCOS lead to pancreatic β cell dysfunction, insulin resist-
ance, and thus hyperglycemia and dyslipidemia [74, 75], 
in addition to the antilipolytic effects of androgens [76]. 
Consistently, our results showed hyperglycemia and sig-
nificant elevation in all lipid profile parameters such as 
cholesterol, triglyceride, LDL, and VLDL with a declined 
HDL level in LTZ induced PCOS rats compared with 
negative control (Table 1), in agreement with other pub-
lished reports [77–79]. Hyperglycemic and dyslipidemic 
effects observed in black cohosh rats were related to 
PCOS, while AR did not affect the lipid profile and glu-
cose in women [80, 81]. However, vitamin C exerted an 
obvious enhancement in glucose and lipid metabolism, 
and increased the HDL levels, which were previously 
detected in both diabetic patients [82] and rats [83].
The dose of 500 mg/kg for vitamin C and 7.14 mg/kg 
for AR was selected based on previous studies [84, 85]. 
This selected dose of AR was also formerly implemented 
to study its effects on PCOS [86] and breast cancer [87] in 
rats and its equivalent was used in clinical trials in women 
[81]. Noteworthy, the No Observed Effect Level (NOEL) 
of AR was defined as 22.5 mg/kg b. wt. in 6-months oral 
toxicity study with its isopropanolic extract in Wistar rats 
[87]. AR extract doses of 0.6–2.25 mg/kg b. wt. in rats is 
like those recommended to postmenopausal women and 
PCOS which is 40–150  mg/day, considering a woman 
weighing 60 kg [24, 73, 88, 89].
Hepatic safety of AR is still a debatable issue. Although, 
we observed a significant increase in the ALT, AST 
and hepatic MDA levels alongside with a reduction in 
hepatic GSH activity in the AR group when compared 
to the negative control, vitamin C and the combination 
group. It was not dramatic changes as supported by the 
pathological finding of only mild hepatocellular necrosis 
with sinusoidal dilation and disorganization of hepatic 
cords (Table 1, Figs. 4a, b, 10d). Similar findings for AR 
Fig. 9 Morphometrical analysis of the percentage of Ki‑67 expression in the ovaries of the different treated groups. a Ki‑67 expression in the 
granulosa cell layer. b Ki‑67 expression in the theca cell layers. c Ki‑67 expression in the interstitial stromal cells. Values with different superscripts are 
significantly different (P < 0.05). PCOS; polycystic ovary syndrome, AR; Actaea racemose, Vit. C; vitamin C
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induced hepatic oxidative damage were reported [28, 90, 
91], which were contradicted in other studies [26, 92]. 
Increased hepatic lipid peroxidation with AR treatment 
was previously observed [89]. Although, no reduction 
was observed in the hepatic GSH with AR 0.6 mg/kg b. 
wt. in ovariectomized female rats, a marked reduction in 
the hepatic GSH of male rats treated with AR (300 mg/
kg) was previously recorded [93]. This discrepancy could 
have been related to lower dosing and hyperandrogenism 
[89]. In addition, PCOS group also showed a minor 
hepatic changes demonstrated by elevated ALT and 
AST levels with a moderate vacuolation of hepatocytes 
(Table 1, Figs. 4a, b, 10b), which is consistent with a pre-
vious study [94], and could be correlated to LTZ effect. 
The later findings could interfere with getting a precise 
conclusion about AR hepatotoxic effect. The mechanism 
for explaining AR suspected hepatotoxicity is still unclear, 
nevertheless, AR contains hepatotoxic constituents such 
Fig. 10 Photomicrographs of hematoxylin and eosin stained sections of the liver in the different treated groups (×400). a Negative control group 
showing normal hepatic architecture, b PCOS group showing moderate vacuolation of hepatocytes. c Clomiphene treated group showing mild 
vacuolation of hepatocytes. d Actaea racemose (AR) treated group showing hepatocellular necrosis with sinusoidal dilation and disorganization 
of hepatic cords. e Vitamin C group showing normal histological findings. f AR combined with vitamin C group showing mild vacuolation of 
hepatocytes with sporadic cell necrosis
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as salicylates and alkaloids, as well as, hepatoprotective 
triterpene glycosides [55].
One interesting finding from our study is that although 
vitamin C had a minor ovarian effect on PCOS, it had a 
protective effect when combined with AR which dimin-
ished the AR induced mild liver deterioration. The 
protective effect of vitamin C may be due to its scav-
enging effect on oxidant molecules that consequentially 
enhances the antioxidant capacity.
Conclusion
The present study demonstrated the ability of Actaea 
racemosa and vitamin C combination to mitigate the 
reproductive and metabolic disorders of PCOS. The AR 
arsenal of secondary metabolites inhibited the androgen 
aromatization in the letrozole-induced PCOS rats, off-
setting ovarian oxidative stress, which may be involved 
in the pathogenesis of PCOS, with enhanced hormonal 
profile, lipid profile, glucose level and liver functions. 
Furthermore, AR or its vitamin C combination increased 
Ki-67 expression in the granulosa cell layer along with a 
significant downregulation of Cyp19-α1 mRNA expres-
sion level. Our results of steroidogenesis modulation 
with a declined risk of hepatic adverse effects by AR and 
vitamin C combination warrant further studies of this 
combination in polycystic ovary syndrome.
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Fig. 11 Effect of Actaea racemose (AR) extract and/or vitamin C on 
the expression level of Cyp19α1 gene in polycystic ovary syndrome 
(PCOS) rat model. Values are presented as mean ± SD. Means carrying 
different letters are significantly different at P < 0.05. PCOS; polycystic 
ovary syndrome, AR; Actaea racemose, Vit. C; vitamin C
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